HLVX
Price
$1.99
Change
+$0.03 (+1.53%)
Updated
Jun 6 closing price
Capitalization
97.95M
60 days until earnings call
IPHYF
Price
$1.45
Change
-$0.31 (-17.61%)
Updated
Apr 11 closing price
Capitalization
202.47M
Interact to see
Advertisement

HLVX vs IPHYF

Header iconHLVX vs IPHYF Comparison
Open Charts HLVX vs IPHYFBanner chart's image
HilleVax
Price$1.99
Change+$0.03 (+1.53%)
Volume$101.29K
Capitalization97.95M
Innate Pharma
Price$1.45
Change-$0.31 (-17.61%)
Volume$2K
Capitalization202.47M
HLVX vs IPHYF Comparison Chart
Loading...
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLVX vs. IPHYF commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLVX is a Buy and IPHYF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (HLVX: $1.83 vs. IPHYF: $1.45)
Brand notoriety: HLVX and IPHYF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HLVX: 42% vs. IPHYF: 113%
Market capitalization -- HLVX: $97.95M vs. IPHYF: $202.47M
HLVX [@Biotechnology] is valued at $97.95M. IPHYF’s [@Biotechnology] market capitalization is $202.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLVX’s FA Score shows that 1 FA rating(s) are green whileIPHYF’s FA Score has 0 green FA rating(s).

  • HLVX’s FA Score: 1 green, 4 red.
  • IPHYF’s FA Score: 0 green, 5 red.
According to our system of comparison, HLVX is a better buy in the long-term than IPHYF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLVX’s TA Score shows that 4 TA indicator(s) are bullish.

  • HLVX’s TA Score: 4 bullish, 5 bearish.

Price Growth

HLVX (@Biotechnology) experienced а -3.68% price change this week, while IPHYF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

HLVX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPHYF($202M) has a higher market cap than HLVX($97.9M). HLVX YTD gains are higher at: -11.594 vs. IPHYF (-50.000).
HLVXIPHYFHLVX / IPHYF
Capitalization97.9M202M48%
EBITDA-143.17MN/A-
Gain YTD-11.594-50.00023%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash189MN/A-
Total Debt25MN/A-
FUNDAMENTALS RATINGS
IPHYF: Fundamental Ratings
IPHYF
OUTLOOK RATING
1..100
45
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HLVX
RSI
ODDS (%)
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
85%
Momentum
ODDS (%)
Bearish Trend 12 days ago
85%
MACD
ODDS (%)
Bearish Trend 12 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
78%
Advances
ODDS (%)
Bullish Trend 24 days ago
83%
Declines
ODDS (%)
Bearish Trend 18 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
87%
Aroon
ODDS (%)
Bullish Trend 12 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

HLVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLVX has been closely correlated with FBIOP. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if HLVX jumps, then FBIOP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLVX
1D Price
Change %
HLVX100%
-1.61%
FBIOP - HLVX
82%
Closely correlated
-0.56%
BRIBF - HLVX
58%
Loosely correlated
N/A
NTLA - HLVX
38%
Loosely correlated
+3.59%
IPHYF - HLVX
38%
Loosely correlated
N/A
PLRX - HLVX
37%
Loosely correlated
+5.47%
More

IPHYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHYF has been loosely correlated with MBIO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHYF jumps, then MBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHYF
1D Price
Change %
IPHYF100%
N/A
MBIO - IPHYF
42%
Loosely correlated
-0.78%
ONPPF - IPHYF
41%
Loosely correlated
N/A
HLVX - IPHYF
38%
Loosely correlated
-1.61%
SLRX - IPHYF
33%
Loosely correlated
-4.17%
RVMD - IPHYF
30%
Poorly correlated
+2.04%
More